MAVORIXAFOR | MAVORIXAFOR | BLOOD CXC CHEMOKINE RECEPTOR 4 (CXCR4) ANTAGONIST TREATMENT OF WHIM SYNDROME (WARTS, HYPOGAMMAGLOBULINEMIA, INFECTIONS AND MYELOKATHEXIS) | ORAL | Cmax 9.45 MICROMOLAR Tmax 2.8 HOUR VD 768 LITER PPB 93 PERCENT Cl 62 LITER / HOUR HT 82 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN PH 7.5 AQUEOUS BUFFER | CXC CHEMOKINE RECEPTOR 4 (CXCR4) | - more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |